Gastrointestinal tract spindle cell tumors with interstitial cells of Cajal: Prevalence excluding gastrointestinal stromal tumors
- Authors:
- So Jung Lee
- Chung Su Hwang
- Ahrong Kim
- Kyungbin Kim
- Kyung Un Choi
View Affiliations
Affiliations: Department of Pathology, Pusan National University Hospital, Busan 49241, Republic of Korea, Department of Pathology, Pusan National University Yangsan Hospital, Yangsan, Gyeongsangnam 50612, Republic of Korea, Department of Pathology, Ulsan University Hospital, Ulsan 44033, Republic of Korea
- Published online on: June 22, 2016 https://doi.org/10.3892/ol.2016.4758
-
Pages:
1287-1292
-
Copyright: © Lee
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Leiomyomas and schwannomas of the gastrointestinal tract (GIT) are mainly comprised of spindle‑shaped tumor cells and should always be differentiated from gastrointestinal stromal tumors (GISTs). Mast/stem cell growth factor receptor Kit (KIT) and discovered on GIST-1 (DOG1) are well‑known diagnostic markers for the detection of a GIST by immunohistochemical staining. The aim of the present study was to assess the prevalence and significance of spindle cell tumors of the GIT with KIT‑ or DOG1‑positive spindle‑shaped cells, presumed to be interstitial cells of Cajal (ICCs), other than GISTs. A total of 71 leiomyomas and 35 schwannomas were examined and clinicopathological information was obtained. KIT and DOG1 immunostaining was performed to determine the proportions of positive cells. Mutation screening of KIT exons 9, 11, 13 and 17, and platelet‑derived growth factor receptor α (PDGFRA) exons 12 and 18 was performed in cases with a relatively high proportion of either KIT‑ or DOG1‑positive cells. The frequency of leiomyomas and schwannomas with KIT‑ and DOG1‑positive ICCs was 35.2% (25/71 cases) and 5.7% (2/35 cases), respectively. Among the esophageal leiomyomas with KIT‑ and DOG‑positive ICCs (14/25; 56.0%), 5 leiomyomas involved the muscularis mucosa and 9 leiomyomas involved the muscularis propria. All gastric leiomyomas with KIT‑ and DOG1‑positive ICCs (11/25; 44%) involved the muscularis propria. All schwannomas with an increased proportion of KIT‑ or DOG1‑positive ICCs were of gastric origin. No KIT or PDGFRA mutations were detected in 7 leiomyomas and 2 schwannomas. In conclusion, the majority of leiomyomas and the minority of schwannomas in the GIT had a significant portion of KIT‑ and DOG1‑positive cells. All of the tumors were located in the upper GIT, and could be present in the muscularis propria or muscularis mucosa. The tumors represented a non‑neoplastic proliferation of KIT‑ and DOG1‑positive cells in the GIT. Careful evaluation of KIT‑ or DOG1‑positive cells in spindle cell tumors of the GIT can assist in forming the correct diagnosis by differentiation from a GIST.
View References
|
1
|
Miettinen M, Sarlomo-Rikala M and Sobin
LH: Mesenchymal tumors of muscularis mucosae of colon and rectum
are benign leiomyomas that should be separated from
gastrointestinal stromal tumors - A clinicopathologic and
immunohistochemical study of eighty-eight cases. Mod Pathol.
14:950–956. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosai J: Gastrointestinal stromal tumor
and its mimics. Int J Surg Pathol. 18(3 Suppl): S79–S87. 2010.
View Article : Google Scholar
|
|
3
|
Kindblom LG, Remotti HE, Aldenborg F and
Meis-Kindblom JM: Gastrointestinal pacemaker cell tumor (GIPACT):
Gastrointestinal stromal tumors show phenotypic characteristics of
the interstitial cells of Cajal. Am J Pathol. 152:1259–1269.
1998.PubMed/NCBI
|
|
4
|
Miettinen M, Wang ZF and Lasota J: DOG1
antibody in the differential diagnosis of gastrointestinal stromal
tumors: A study of 1840 cases. Am J Surg Pathol. 33:1401–1408.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miettinen M, Sobin LH and Lasota J:
Gastrointestinal stromal tumors of the stomach: A
clinicopathologic, immunohistochemical, and molecular genetic study
of 1765 cases with long-term follow-up. Am J Surg Pathol. 29:52–68.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumors-definition, clinical, histological,
immunohistochemical, and molecular genetic features and
differential diagnosis. Virchows Arch. 438:1–12. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
West RB, Corless CL, Chen X, Rubin BP,
Subramanian S, Montgomery K, Zhu S, Ball CA, Nielsen TO, Patel R,
et al: The novel marker, DOG1, is expressed ubiquitously in
gastrointestinal stromal tumors irrespective of KIT or PDGFRA
mutation status. Am J Pathol. 165:107–113. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim JM, Kim A, Choi JH and Bae YK:
Usefulness of DOG1 expression in the diagnosis of gastrointestinal
stromal tumors. Korean J Pathol. 44:141–148. 2010. View Article : Google Scholar
|
|
9
|
Deshpande A, Nelson D, Corless CL,
Deshpande V and O'Brien MJ: Leiomyoma of the gastrointestinal tract
with interstitial cells of Cajal: A mimic of gastrointestinal
stromal tumor. Am J Surg Pathol. 38:72–77. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miettinen M, Sarlomo-Rikala M, Sobin LH
and Lasota J: Esophageal stromal tumors: A clinicopathologic,
immunohistochemical, and molecular genetic study of 17 cases and
comparison with esophageal leiomyomas and leiomyosarcomas. Am J
Surg Pathol. 24:211–222. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hou YY, Tan YS, Xu JF, Wang XN, Lu SH, Ji
Y, Wang J and Zhu XZ: Schwannoma of the gastrointestinal tract: A
clinicopathological, immunohistochemical and ultrastructural study
of 33 cases. Histopathology. 48:536–545. 2006. View Article : Google Scholar : PubMed/NCBI
|
